Switch to:
Also traded in: France, Germany, Italy, Mexico, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.20
ESLOY's Cash to Debt is ranked lower than
83% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. ESLOY: 0.20 )
Ranked among companies with meaningful Cash to Debt only.
ESLOY' s Cash to Debt Range Over the Past 10 Years
Min: 0.2  Med: 1.02 Max: N/A
Current: 0.2
Equity to Asset 0.49
ESLOY's Equity to Asset is ranked lower than
66% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. ESLOY: 0.49 )
Ranked among companies with meaningful Equity to Asset only.
ESLOY' s Equity to Asset Range Over the Past 10 Years
Min: 0.43  Med: 0.52 Max: 0.65
Current: 0.49
0.43
0.65
Interest Coverage 15.42
ESLOY's Interest Coverage is ranked lower than
62% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 39.77 vs. ESLOY: 15.42 )
Ranked among companies with meaningful Interest Coverage only.
ESLOY' s Interest Coverage Range Over the Past 10 Years
Min: 6.87  Med: 23.56 Max: N/A
Current: 15.42
F-Score: 5
Z-Score: 3.06
M-Score: -2.45
WACC vs ROIC
5.38%
10.98%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 17.63
ESLOY's Operating margin (%) is ranked higher than
85% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.89 vs. ESLOY: 17.63 )
Ranked among companies with meaningful Operating margin (%) only.
ESLOY' s Operating margin (%) Range Over the Past 10 Years
Min: 15.89  Med: 16.79 Max: 21.55
Current: 17.63
15.89
21.55
Net-margin (%) 11.39
ESLOY's Net-margin (%) is ranked higher than
77% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.04 vs. ESLOY: 11.39 )
Ranked among companies with meaningful Net-margin (%) only.
ESLOY' s Net-margin (%) Range Over the Past 10 Years
Min: 11.27  Med: 12.16 Max: 16.38
Current: 11.39
11.27
16.38
ROE (%) 13.78
ESLOY's ROE (%) is ranked higher than
78% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.88 vs. ESLOY: 13.78 )
Ranked among companies with meaningful ROE (%) only.
ESLOY' s ROE (%) Range Over the Past 10 Years
Min: 13.78  Med: 16.45 Max: 21.43
Current: 13.78
13.78
21.43
ROA (%) 6.57
ESLOY's ROA (%) is ranked higher than
72% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.61 vs. ESLOY: 6.57 )
Ranked among companies with meaningful ROA (%) only.
ESLOY' s ROA (%) Range Over the Past 10 Years
Min: 6.57  Med: 9.88 Max: 11.16
Current: 6.57
6.57
11.16
ROC (Joel Greenblatt) (%) 63.04
ESLOY's ROC (Joel Greenblatt) (%) is ranked higher than
89% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.16 vs. ESLOY: 63.04 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ESLOY' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 49.72  Med: 59.78 Max: 72.81
Current: 63.04
49.72
72.81
Revenue Growth (3Y)(%) 9.50
ESLOY's Revenue Growth (3Y)(%) is ranked higher than
73% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. ESLOY: 9.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ESLOY' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -0.5  Med: 9.3 Max: 15.1
Current: 9.5
-0.5
15.1
EBITDA Growth (3Y)(%) 13.00
ESLOY's EBITDA Growth (3Y)(%) is ranked higher than
69% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. ESLOY: 13.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ESLOY' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -2.2  Med: 8.5 Max: 23.8
Current: 13
-2.2
23.8
EPS Growth (3Y)(%) 8.10
ESLOY's EPS Growth (3Y)(%) is ranked higher than
55% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. ESLOY: 8.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ESLOY' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 6.6  Med: 11.9 Max: 21.5
Current: 8.1
6.6
21.5
» ESLOY's 10-Y Financials

Financials (Next Earnings Date: Est. 2017-07-29)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with ESLOY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NAS:ILMN, NYSE:BAX, NYSE:BCR, NAS:XRAY, OTCPK:TRUMF, OTCPK:OCPNY, NYSE:WAT, NYSE:MTD, NAS:HOLX, OTCPK:RSMDF, NYSE:BDX, NYSE:COO, NYSE:WST, OTCPK:SAUHY, NYSE:STE, OTCPK:GNGBY, NYSE:HRC, NYSE:CMN, OTCPK:ANSLY, NAS:ICUI » details
Traded in other countries:EI.France, ESL.Germany, EI.Italy, EI N.Mexico, EI.Switzerland, 0OMK.UK,
Essilor International SA designs, manufactures, purchases, sells and trades all eyewear and optical products. It also manufactures, purchases and sales frames, sunglasses, protective lenses and other protective equipment.

Essilor International SA was formed on October 6, 1971. The Company designs, manufactures, purchases, sells and trades all eyewear and optical products. It also manufactures, purchases and sales frames, sunglasses, protective lenses and other protective equipment, and eyeglass and contact lenses. The Company operates in three business segments: Lenses & Optical Instruments, Equipment, and Readers. The Lenses & Optical Instruments business segment comprises the Lens business (production, finishing, distribution and trading) and the Instruments business (small equipment used by opticians and relating to the sale of lenses). The end customers for this business are eye care professionals. The Equipment business segment comprises the production, distribution and sale of high capacity equipment, such as digital surfacing machines and lens polishing machines, used in manufacturing plants and prescription laboratories for finishing operations on semi-finished lenses. The end customers for this business segment are optical lens manufacturers. The Readers business segment comprises the production, distribution and sale of non-prescription reading glasses and sunglasses. The end customers for this segment are retailers that sell non-prescription reading glasses to consumers. It operates in North America, Europe, Asia-Pacific/Middle East/Africa, and Latin America. The Company's competitors are Hoya (Japan) and Carl Zeiss Vision (Germany).

Ratios

vs
industry
vs
history
P/E(ttm) 27.74
ESLOY's P/E(ttm) is ranked higher than
54% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.20 vs. ESLOY: 27.74 )
Ranked among companies with meaningful P/E(ttm) only.
ESLOY' s P/E(ttm) Range Over the Past 10 Years
Min: 13.32  Med: 26.39 Max: 57.75
Current: 27.74
13.32
57.75
Forward P/E 22.78
ESLOY's Forward P/E is ranked lower than
51% of the 35 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.22 vs. ESLOY: 22.78 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 27.74
ESLOY's PE(NRI) is ranked higher than
52% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.71 vs. ESLOY: 27.74 )
Ranked among companies with meaningful PE(NRI) only.
ESLOY' s PE(NRI) Range Over the Past 10 Years
Min: 13.32  Med: 26.39 Max: 57.75
Current: 27.74
13.32
57.75
Price/Owner Earnings (ttm) 22.21
ESLOY's Price/Owner Earnings (ttm) is ranked higher than
62% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.97 vs. ESLOY: 22.21 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
ESLOY' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 12.17  Med: 23.3 Max: 63.85
Current: 22.21
12.17
63.85
P/B 3.60
ESLOY's P/B is ranked lower than
55% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. ESLOY: 3.60 )
Ranked among companies with meaningful P/B only.
ESLOY' s P/B Range Over the Past 10 Years
Min: 2.26  Med: 4.23 Max: 9.89
Current: 3.6
2.26
9.89
P/S 3.24
ESLOY's P/S is ranked lower than
54% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. ESLOY: 3.24 )
Ranked among companies with meaningful P/S only.
ESLOY' s P/S Range Over the Past 10 Years
Min: 1.63  Med: 3.26 Max: 7.2
Current: 3.24
1.63
7.2
PFCF 25.10
ESLOY's PFCF is ranked higher than
59% of the 78 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.13 vs. ESLOY: 25.10 )
Ranked among companies with meaningful PFCF only.
ESLOY' s PFCF Range Over the Past 10 Years
Min: 17.98  Med: 28.79 Max: 78.6
Current: 25.1
17.98
78.6
POCF 18.20
ESLOY's POCF is ranked lower than
55% of the 99 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.52 vs. ESLOY: 18.20 )
Ranked among companies with meaningful POCF only.
ESLOY' s POCF Range Over the Past 10 Years
Min: 9.94  Med: 19.75 Max: 42.94
Current: 18.2
9.94
42.94
EV-to-EBIT 20.25
ESLOY's EV-to-EBIT is ranked higher than
59% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.32 vs. ESLOY: 20.25 )
Ranked among companies with meaningful EV-to-EBIT only.
ESLOY' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.9  Med: 19.3 Max: 40.3
Current: 20.25
8.9
40.3
EV-to-EBITDA 15.35
ESLOY's EV-to-EBITDA is ranked higher than
56% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.51 vs. ESLOY: 15.35 )
Ranked among companies with meaningful EV-to-EBITDA only.
ESLOY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.1  Med: 14.9 Max: 31.4
Current: 15.35
7.1
31.4
PEG 1.83
ESLOY's PEG is ranked higher than
67% of the 61 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. ESLOY: 1.83 )
Ranked among companies with meaningful PEG only.
ESLOY' s PEG Range Over the Past 10 Years
Min: 1.29  Med: 2.81 Max: 25.33
Current: 1.83
1.29
25.33
Shiller P/E 38.15
ESLOY's Shiller P/E is ranked higher than
54% of the 46 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 40.02 vs. ESLOY: 38.15 )
Ranked among companies with meaningful Shiller P/E only.
ESLOY' s Shiller P/E Range Over the Past 10 Years
Min: 29.65  Med: 40.97 Max: 50.97
Current: 38.15
29.65
50.97
Current Ratio 1.09
ESLOY's Current Ratio is ranked lower than
86% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.44 vs. ESLOY: 1.09 )
Ranked among companies with meaningful Current Ratio only.
ESLOY' s Current Ratio Range Over the Past 10 Years
Min: 1.07  Med: 1.47 Max: 2.57
Current: 1.09
1.07
2.57
Quick Ratio 0.73
ESLOY's Quick Ratio is ranked lower than
84% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. ESLOY: 0.73 )
Ranked among companies with meaningful Quick Ratio only.
ESLOY' s Quick Ratio Range Over the Past 10 Years
Min: 0.73  Med: 1.03 Max: 2.03
Current: 0.73
0.73
2.03
Days Inventory 145.17
ESLOY's Days Inventory is ranked lower than
62% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 122.94 vs. ESLOY: 145.17 )
Ranked among companies with meaningful Days Inventory only.
ESLOY' s Days Inventory Range Over the Past 10 Years
Min: 113.1  Med: 126.62 Max: 145.17
Current: 145.17
113.1
145.17

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.19
ESLOY's Dividend Yield is ranked lower than
55% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. ESLOY: 1.19 )
Ranked among companies with meaningful Dividend Yield only.
ESLOY' s Dividend Yield Range Over the Past 10 Years
Min: 0.76  Med: 1.35 Max: 7.37
Current: 1.19
0.76
7.37
Dividend Payout 0.31
ESLOY's Dividend Payout is ranked higher than
53% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.31 vs. ESLOY: 0.31 )
Ranked among companies with meaningful Dividend Payout only.
ESLOY' s Dividend Payout Range Over the Past 10 Years
Min: 0.29  Med: 0.6 Max: 0.75
Current: 0.31
0.29
0.75
Dividend Growth (3y) 6.30
ESLOY's Dividend Growth (3y) is ranked lower than
65% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.90 vs. ESLOY: 6.30 )
Ranked among companies with meaningful Dividend Growth (3y) only.
ESLOY' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 7.1 Max: 45.5
Current: 6.3
0
45.5
Forward Dividend Yield 1.20
ESLOY's Forward Dividend Yield is ranked lower than
59% of the 141 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. ESLOY: 1.20 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 1.67
ESLOY's Yield on cost (5-Year) is ranked lower than
53% of the 172 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.75 vs. ESLOY: 1.67 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
ESLOY' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.06  Med: 1.88 Max: 10.24
Current: 1.67
1.06
10.24
3-Year Average Share Buyback Ratio 0.20
ESLOY's 3-Year Average Share Buyback Ratio is ranked higher than
84% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.10 vs. ESLOY: 0.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ESLOY' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.2  Med: -0.4 Max: 0.4
Current: 0.2
-1.2
0.4

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.57
ESLOY's Price/Projected FCF is ranked lower than
99.99% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. ESLOY: 1.57 )
Ranked among companies with meaningful Price/Projected FCF only.
ESLOY' s Price/Projected FCF Range Over the Past 10 Years
Min: 0  Med: 1.7 Max: 2.31
Current: 1.57
0
2.31
Price/DCF (Earnings Based) 1.79
ESLOY's Price/DCF (Earnings Based) is ranked higher than
62% of the 16 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.98 vs. ESLOY: 1.79 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.00
ESLOY's Price/Median PS Value is ranked lower than
99.99% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. ESLOY: 1.00 )
Ranked among companies with meaningful Price/Median PS Value only.
ESLOY' s Price/Median PS Value Range Over the Past 10 Years
Min: 0  Med: 0.87 Max: 1.14
Current: 1
0
1.14
Price/Peter Lynch Fair Value 1.86
ESLOY's Price/Peter Lynch Fair Value is ranked lower than
99.99% of the 37 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.63 vs. ESLOY: 1.86 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
ESLOY' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0  Med: 2.34 Max: 3.27
Current: 1.86
0
3.27
Earnings Yield (Greenblatt) (%) 4.94
ESLOY's Earnings Yield (Greenblatt) (%) is ranked higher than
74% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. ESLOY: 4.94 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ESLOY' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.5  Med: 5.2 Max: 11.2
Current: 4.94
2.5
11.2
Forward Rate of Return (Yacktman) (%) 18.43
ESLOY's Forward Rate of Return (Yacktman) (%) is ranked higher than
79% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.00 vs. ESLOY: 18.43 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ESLOY' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 1.8  Med: 11.7 Max: 18.6
Current: 18.43
1.8
18.6

More Statistics

Revenue (TTM) (Mil) $7,629
EPS (TTM) $ 2.00
Beta0.90
Short Percentage of Float0.00%
52-Week Range $50.35 - 67.99
Shares Outstanding (Mil)430.48

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 7,414 7,924 8,754
EPS ($) 2.12 2.35 2.50
EPS w/o NRI ($) 2.12 2.35 2.50
EPS Growth Rate
(3Y to 5Y Estimate)
10.46%
Dividends Per Share ($) 0.60 0.69 0.82
» More Articles for ESLOY

Headlines

Articles On GuruFocus.com
Chris Davis Comments on Essilor International SA Sep 09 2014 
Chris Davis International Fund Semi-Annual Portfolio Review Sep 08 2014 

More From Other Websites
Essilor Stock Falls Sharply After Revenue Guidance Cut Nov 22 2016
Essilor Expands in China. Essilor updates 2016 expectations and confirms its robust medium-term... Nov 22 2016
Essilor launches a plan to enable 50% of employees worldwide to become shareholders Sep 28 2016
Essilor and Gladwin agree to settle IP infringement litigation Sep 13 2016
Essilor broadens online footprint in Europe by acquiring MyOptique Group Aug 16 2016
Essilor International SA :ESLOY-US: Earnings Analysis: For the six months ended June 30, 2016 :... Aug 09 2016
Business Call to Action welcomes Essilor as it's newest member. Aug 02 2016
First-Half 2016 Results: Revenue Up 8.1% Excluding the Currency Effect Jul 28 2016
Publication of the 2016 Interim Financial Report Jul 28 2016
Essilor named No. 5 in Newsweek's 2016 Green Rankings Jun 13 2016
Essilor named No. 5 in Newsweek’s 2016 Green Rankings Jun 13 2016
Result of the payment of dividends in shares and record of the corresponding capital increase Jun 03 2016
2016 Annual General Meeting: All resolutions approved May 11 2016
First-Quarter 2016 Report: Revenue up a Robust 9.4% Excl. the Currency Effect Apr 20 2016
Proxy Information for the Combined Annual Meeting on May 11, 2016 Mar 30 2016
Essilor International SA Earnings Analysis: 2015 By the Numbers Feb 22 2016
Essilor’s Inclusive Business Model Eye Mitra Creates Strong Socio-Economic Impact Jan 26 2016
Anne Hathaway becomes brand ambassador of Bolon, leading Chinese Eyewear brand Jan 14 2016
Anne Hathaway becomes brand ambassador of Bolon, leading Chinese Eyewear brand Jan 11 2016
Essilor pursues its partnership strategy by signing nine new transactions Jan 08 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)